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Objectives This study sought to investigate the extent of and factors related to lumen and vessel
area change in coronary arteries after total occlusion (TO) recanalization.
Background TO of a coronary artery promotes negative remodeling in distal reference segments.
Recanalization can restore blood ﬂow, potentially leading to positive vascular remodeling.
Methods From March 2005 to June 2008, 58 consecutive patients with de novo TO lesions of at
least 1-month duration were enrolled. We performed intravascular ultrasound after successful percu-
taneous coronary intervention and at the 6-month follow-up, and we quantiﬁed changes in the dis-
tal reference segments.
Results At the 6-month follow-up, there was a signiﬁcant increase in the mean lumen diameter
(0.21 mm, p  0.001), the mean external elastic membrane diameter (0.13 mm, p  0.010), the
lumen area (0.87 mm2, p  0.001), and the external elastic membrane area (0.85 mm2,
 0.001) in the distal reference segments and an increase in the left ventricular ejection fraction
(2.77%, p  0.010). Overall, 40 of 58 patients (69%) showed lumen area increase; these patients
had increase in lumen diameter by 0.40  0.34 mm (p  0.001) and increase in incomplete stent
apposition rate (p  0.006). A TO duration of longer than 3 months (odds ratio [OR]: 14.8; 95% con-
ﬁdence interval [CI]: 1.28 to 172.8, p  0.032), a poor collateral ﬂow (OR: 12.0; 95% CI: 1.92 to 74.2,
p  0.008), and statin use (OR: 7.4; 95% CI: 1.03 to 53.6, p  0.047) were independent predictors of
lumen area increase.
Conclusions Recanalization of TO led to lumen area increase in two-thirds of the patients. Indepen-
dent predictors of lumen area increase were occlusion duration, a poor collateral ﬂow, and statin
use. These factors could be used as guides in choosing the optimal stent size during percutaneous
coronary intervention to TO lesions and optimal medical therapy during follow-up. (J Am Coll
Cardiol Intv 2012;5:827–36) © 2012 by the American College of Cardiology Foundation
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828Vascular remodeling is a homeostatic response to changes in
flow and circumferential stretch to maintain or restore
normal shear stress and wall tension (1). In the presence of
stable atherosclerotic lesions, the remodeling process pri-
marily causes luminal narrowing of the lesional and extra-
lesional vessel segments (2). Blood vessels can enlarge to
accommodate increasing flow to the organs downstream,
and it is known that luminal stenosis correlates more closely
with the direction and magnitude of remodeling than with
plaque size (3). In patients with a total occlusion (TO) of a
coronary artery, reduced blood flow in distal reference
segments might promote both negative vascular wall re-
modeling and plaque growth, as shown in animal models
with carotid arteries (4).
TO, including chronic total
occlusion (CTO), occurs fre-
quently, with a reported inci-
dence of 30% to 50% among
patients with significant coro-
nary artery disease (5). Despite
the development of novel tech-
niques and devices in the field of
percutaneous coronary interven-
tion (PCI), the recanalization of
TO still remains complex and
challenging (6,7). Successful TO
recanalization has been associ-
ated with a significant improve-
ment in angina symptoms (8–10).
The recanalization of TO may
improve distal blood flow. But,
it is unknown whether the flow
restoration can influence the re-
modeling process in the distal ref-
erence segments in humans.
Hence, we sought to deter-
mine the degree of remodeling
of distal reference segments after
successful recanalization of TO
by intravascular ultrasound (IVUS)
and the factors that influence the remodeling process in a
prospective TO-IVUS cohort at our institution.
Methods
Patients. From March 2005 to June 2008, we consecutively
enrolled patients with de novo TO who were successfully
recanalized at our institution. TO was defined as a lesion
exhibiting a TIMI (Thrombolysis In Myocardial Infarction)
flow grade of 0 to 1 for more than 1 month. All patients had
at least 1 occlusion within a major epicardial coronary artery.
Immediately after successful recanalization, the patients
underwent an IVUS exam for the measurement of vessel
Abbreviations
and Acronyms
CI  confidence interval
CTO  chronic total
occlusion
EEM  external elastic
membrane
IQR  interquartile range
ISA  incomplete stent
apposition
IVUS  intravascular
ultrasound
LV  left ventricular
LVEF  left ventricular
ejection fraction
OR  odds ratio
PCI  percutaneous
coronary intervention
TIMI  Thrombolysis In
Myocardial Infarction
TO  total occlusion of a
coronary artery
ZES  zotarolimus-eluting
stent(s)and lumen size. Patients with acute myocardial infarctionwithin 1 month were excluded in addition to those with
total occlusion of the left main coronary artery or arterial or
vein graft lesions. All patients underwent follow-up coro-
nary angiography, and those without significant in-stent
restenosis (diameter stenosis 50%) of previously recana-
lized TO underwent follow-up IVUS examination for
evaluation of the distal reference segments.
Hence, 58 patients with successfully recanalized TO, an
IVUS exam at the index PCI and 6-month follow-up
coronary angiography were enrolled. End-diastolic and
end-systolic left ventricular (LV) volumes were measured in
the apical 4- and 2-chamber view with a modified Simpson
method. The LV ejection fraction was subsequently calcu-
lated. Written informed consent for study participation was
obtained from each patient before enrollment. The study
complied with the Declaration of Helsinki and was ap-
proved by the Institutional Review Board of Seoul National
University Bundang Hospital.
Deﬁnitions. The duration of the occlusion was determined
y the interval from the last episode of acute coronary
yndrome, from the first episode of effort angina consistent
ith the location of the occlusion in patients without a
istory of acute coronary syndrome, or by a previous
oronary angiography. In patients without a history of
ngina, the changes in noninvasive tests (i.e., electrocardi-
graphy or echocardiography) and stress tests (i.e., exercise
lectrocardiography, myocardial perfusion imaging, or
obutamine-stress echocardiography) were considered.
TO was defined as TO with a duration longer than 3
onths (6,7). Positive vascular remodeling was defined as
xternal elastic membrane (EEM) area increase at the
ollow-up (11). Successful recanalization was defined as a
estoration of TIMI flow grade 3 with residual stenosis30%.
Calcification was identified as readily apparent radiopac-
ties within the vascular wall at the site of the occlusion and
as classified as none/mild, moderate (radiopacities noted
nly during the cardiac cycle before contrast injection), and
evere (radiopacities noted without cardiac motion before
ontrast injection generally compromising both sides of the
rterial lumen) (12).
IVUS examination. After successful TO recanalization,
VUS was carried out in all patients 2 min after intracoro-
ary injection of 200 g of nitroglycerin. The imaging
catheter (Eagle Eye, Volcano Corp., Rancho Cordova,
California) with a 20-MHz phased-array transducer was
advanced at least 20 mm beyond the stent, and a mechanical
pullback was performed at 0.5 mm/s. The point of mea-
surement was 10 mm distal from the stent distal edge to
exclude the effect of the stenting procedure. To assess
exactly the same segment between the index and the
6-month follow-up, we used geometric markers, such as the
distance to stent edge and relationship to side branches
during the IVUS analysis. The following measurements
were obtained: the mean lumen diameter, the mean EEM
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829diameter, the lumen area, the plaque and media area, and
the EEM area. Lumen area increase was defined as any
lumen area increase at the 6-month follow-up. The IVUS
analysis was performed by 2 independent experienced ob-
servers who were blinded to the angiographic results.
Qualitative analysis included incomplete stent apposition
(blood speckle behind stent struts), stent fracture (absence
of struts over more than one-third of the stent circumfer-
ence), aneurysm (lumen 50% larger than the proximal
reference), and edge dissection. Incomplete stent apposition
was defined as at least 1 stent strut clearly separated from
the vessel wall with evidence of blood speckles behind the
strut not associated with any side branches.
Statistical analysis. The data were presented as numbers and
requencies for categorical variables and as the mean  SD
or continuous variables. For comparison between groups,
he chi-square test (or Fisher exact test when any expected
ell count was5 for a 2 2 table) was used for categorical
ariables, and the Mann-Whitney U test and the Kruskal-
allis test were applied for continuous variables. For
hanges between the index and the 6-month follow-up, a
aired t test and the McNemar test were used. A multivar-
ate logistic regression analysis was performed to determine
he independent predictors of lumen area increase. Factors
ntered into the multivariate model included those with p
alues 0.10 from the univariate analysis along with com-
on cardiovascular risk factors. Two-sided p values 0.05
ere considered statistically significant. Statistical tests were
erformed using SPSS software (version 17, SPSS Inc.,
hicago, Illinois).
esults
A total of 105 patients were initially enrolled in the
TO-IVUS cohort. Six patients turned out not to have TO
as defined by the definition. At the 6-month follow-up, 1
patient had died; 4 patients became lost to follow-up; and
15 patients refused hospital admissions for the follow-up
coronary angiography. Among the 79 patients who under-
went follow-up coronary angiography, 5 patients had in-
stent restenosis 50%; 7 patients refused the IVUS exam;
and 1 patient had an unsuccessful IVUS exam due to
passage failure of the IVUS catheter. In 5 patients, the distal
reference segment was too thin and/or tortuous to fully
advance the transducer at least 20 mm beyond the stent
edge, and in 3 patients, the quality of IVUS recording was
too poor to perform an accurate measurement, leaving 58
patients available for the final analysis (Online Fig. 1). The
clinical and angiographic characteristics along with qualita-
tive IVUS analysis of the study patients are summarized in
Tables 1 and 2. Overall, the mean age was 59.9 years, and
most patients were men (82.8%). Thirty-seven (63.8%)
patients initially presented with stable angina, and 21
(36.2%) presented with acute coronary syndrome. Twenty- bfour percent of the patients had 1-vessel disease, whereas
76% had multivessel disease. TO was most frequently
localized in the left anterior descending artery. Rentrop’s
grade 3 collateral flow to the distal reference segments was
present only in 11.5%.
The IVUS exam of the distal reference segments at the
6-month follow-up revealed that there was a significant
increase in the mean lumen diameter by0.21 mm (10.4
19.9%) (2.24  0.48 mm¡ 2.45  0.59 mm, p  0.001),
n the mean EEM diameter by 0.13 mm (5.8  14.9%)
2.91  0.70 mm ¡ 3.05  0.69 mm, p  0.010), in the
umen area by 0.87 mm2 (29.6  50.8%) (4.00  1.90
m2 ¡ 4.87  2.38 mm2, p  0.001), and in the EEM
area by 0.85 mm2 (17.3  36.2%) (6.80  3.21 mm2 ¡
.65  3.41 mm2, p  0.001), but not in the plaque and
edia area (0.05 mm2 [24.5 124.6%]) (2.83 2.35 mm2¡
2.78  2.30 mm2, p  0.768) (Fig. 1).
Only 40 patients (69%) had increases in lumen areas,
hereas 31% had unchanged or decreased lumen areas
Fig. 2). Among those with lumen area increase, the mean
umen diameter increased by 0.40  0.34 mm (18.9 
7.3%) (2.19  0.41 mm¡ 2.59  0.53 mm, p  0.001).
s for the heart function change during the follow-up
eriod, there was a significant increase in the left ventricular
jection fraction (LVEF) of 2.77% (57.3  9.9% ¡
0.1  8.3%, p  0.010) (Online Fig. 2). When defining
EM area increase as positive remodeling (11), only patients
ith positive vascular remodeling showed a significant increase
n LVEF of 3.6% (56.3  8.8%¡ 60.0  8.8%, p  0.014),
whereas those without positive remodeling did not show any
change in LVEF (60.0  6.7%¡ 60.3  7.3%, p  0.460).
We also investigated whether changes in lumen area are
associated with the incidence of incomplete stent apposition
(ISA). In general, 12 patients (20.7%) had ISA at baseline;
and after 6 months, the number of patients with ISA
increased significantly to 25 patients (43.1%) (p  0.002).
When stratifying the patients according to the lumen area
change, the proportion of patients with ISA increased
significantly in patients with lumen area increase during the
follow-up period (8 patients [20%] at baseline¡18 patients
[45%] at 6-month follow-up, p  0.006), but not in those
without lumen area increase (4 patients [22.2%] at baseline
¡7 patients [38.9%] at 6-month follow-up, p  0.375)
(Tables 2 and 3).
As for drug-eluting stent types, both first- (sirolimus-
eluting stent  paclitaxel-eluting stent) and second-
generation drug-eluting stents (zotarolimus-eluting stent
[ZES]) showed a significant increase in lumen area in the
distal reference segments (3.84  0.72 mm2 ¡ 4.78 
.35 mm2, p  0.001 for sirolimus-eluting stent  paclitaxel-
luting stent, 3.68 0.72¡ 4.56 1.11, p 0.044 for ZES).
here was no difference in the degree of lumen area increase
etween both stent generations (0.94  1.80 mm2 for
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830sirolimus-eluting stent  paclitaxel-eluting stent vs. 0.88 
1.10 mm2 for ZES, p  0.922).
During clinical follow-up, only 1 patient with lumen area
ncrease had a myocardial infarction 5 months after TO
ecanalization. To be more precise, the patient underwent
ight coronary artery TO recanalization at the index PCI,
ut the culprit artery of the myocardial infarction at 5
onths was the left main artery. Cardiac death, myocardial
nfarction, or stent thrombosis was not observed in the
emaining 57 patients.
Patients with lumen area increase had a significantly
onger TO duration (4.5 months, [interquartile range
IQR): 2 to 23 months] vs. 1.5 months [IQR: 1 to 8
onths], p  0.020) and had more frequent poor collateral
ow (grade 0 to 2, 95% vs. 73%, p 0.050), compared with
Table 1. Baseline Characteristics
All
(N  58
Demographic characteristics
Age, yrs 59.9 1
Men 48 (82.8
Hypertension 33 (56.9
Diabetes mellitus 21 (36.2
Current smokers 28 (48.3
Dyslipidemia 20 (34.5
Previous CABG 0 (0)
Previous myocardial infarction 7 (12.1
Clinical presentation
Stable angina 37 (63.8
Acute coronary syndrome 21 (36.2
TO duration, months 3.0 (1–12
CTO 34 (58.6
Laboratory ﬁnding
Creatinine, mg/dl, n  57 1.08 0
hsCRP, mg/l, n  47 1.05 2
NT-proBNP, n  47 529.8 1
Medication
Statins 48 (82.8
ACEI/ARB 42 (72.4
Beta blockers 31 (53.4
DHP-CCB 21 (36.2
Non-DHP-CCB 6 (10.3
Nitrate 5 (8.6)
Functional test
Q waves in ECG 11 (19.0
Positive treadmill test 17 (29.3
Positive SPECT test 14 (24.1
Echocardiographic RWM abnormality, n  55 15 (25.9
LVEF, % 57.4 9
LVEF 50% 7 (12.1those without lumen area increase. The rates for left anteriordescending artery TO (58% vs. 33%, p  0.089) and
single-vessel disease (30% vs. 11%, p  0.062) tended to be
higher in the lumen area increase group than in those
without lumen area increase. There was a positive correla-
tion between the TO duration and the lumen area change
(r 0.293, Spearman rho, p 0.026). When classifying the
distal reference segment according to its location—mid-
versus distal vessel location according to the CASS (Coro-
nary Artery Surgery Study) system—the location of the
distal reference segment was not associated with lumen area
change (p  0.113), although the distal reference segment
was more likely to be located in mid-vessel in patients with
lumen area increase (37.5% vs. 16.7%), and in distal vessel in
those without lumen area increase (62.5% vs. 83.3%). The
degree of calcification was not associated with lumen area
Vessel Remodeling at 6 Months
p Value
umen Area Increase
(n  40, 69%)
No Lumen Area Increase
(n  18, 31%)
59.6 11.6 60.5 7.5 0.853
32 (80.0) 16 (88.9) 0.708
22 (55.0) 11 (61.1) 0.664
12 (30.0) 9 (50.0) 0.143
19 (45.0) 10 (55.6) 0.555
13 (32.5) 7 (38.9) 0.636
0 (0) 0 (0) NA
4 (10.0) 3 (16.7) 0.665
0.143
28 (70.0) 9 (50.0%)
12 (30.0) 9 (50.0%)
4.5 (2–23) 1.5 (1–8) 0.020
28 (70.0%) 6 (33.3%) 0.009
1.08 0.23 1.07 0.22 0.825
0.42 0.66. 2.26 3.78 0.198
431 962 738 1,720 0.855
36 (90.0) 12 (66.7) 0.055
28 (70.0) 14 (77.8) 0.752
20 (50.0) 11 (61.1) 0.433
15 (37.5) 6 (33.3) 0.760
5 (12.5) 1 (5.6) 0.655
3 (7.5) 2 (11.1) 0.641
9 (23.1) 2 (11.1) 0.473
13 (32.5) 4 (22.2) 0.426
9 (17.5) 20 (38.9) 0.102
10 (27.0) 5 (27.8) 0.999
57.6 8.8 56.9 11.8 0.753
4 (10.8) 3 (16.7) 0.671
Continued on next page)
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831cation: 87.5% vs. 83.3%; the proportion of patients with
moderate calcification: 10.0% vs. 16.7%; the proportion of
patients with severe calcification: 2.5% vs. 0.0%, in lumen
area increase group vs. in no lumen area increase group,
respectively, p  0.627).
The concomitant medications did not differ between
patients with and without lumen area increase, although the
Table 1. Continued
All
(N  58)
Angiographic ﬁndings
CAD extent
1-VD 14 (24.1)
2-VD 29 (50.0)
3-VD 15 (25.9)
TO vessel
Left anterior descending artery 29 (50.0)
Left circumﬂex artery 9 (15.5)
Right coronary artery 20 (34.5)
LAD vs. non-LAD
Non-LAD 29 (50.0)
Calciﬁcation
None/mild 50 (86.2)
Moderate 7 (12.1)
Severe 1 (1.7)
Location of the distal reference segment
In mid vessel 18 (31.0)
In distal vessel 40 (69.0)
Collateral ﬂow grade, n  52
0 1 (1.9)
1 11 (21.2)
2 34 (65.4)
3 6 (11.5)
Poor collateral ﬂow, grade 0–2 46 (88.5)
Good collateral ﬂow (grade 3) 6 (11.5)
PCI data
Stent type
Bare-metal stent 1 (1.7)
SES 34 (58.6)
PES 14 (24.1)
ZES 9 (15.5)
1st generation (SES  PES) vs. ZES 48 (84.2)
Stent number per TO lesion 1.8 7.3
Total stent length per TO lesion, mm 48.1 22.0
Stent length 40 mm 33 (56.9)
Values are mean SD, n (%), or median (interquartile range). CTO was
ACEI  angiotensin-converting enzyme inhibitor; ARB  angioten
artery disease; CCB  calcium channel blockers; CTO  chronic tota
high-sensitivity C-reactive protein; LAD  left anterior descending arter
N-terminalpro–B-typenatriureticpeptide; PCIpercutaneous corona
SES  sirolimus-eluting stent(s); SPECT  single-photon emission c
zotarolimus-eluting stent(s).proportion of patients with statin use seemed to be higher inpatients with lumen area increase than in those without
lumen area increase (90.0% vs. 66.7%, p  0.055).
The clinical factors in Table 1 with p  0.10, such as a
TO duration 3 months, a poor collateral flow (grade 0 to
2), the coronary artery disease extent, and the TO location,
and statin use were entered into a multivariate analysis along
with common cardiovascular risk factors, such as age (in
Vessel Remodeling at 6 Months
p Value
men Area Increase
(n  40, 69%)
No Lumen Area Increase
(n  18, 31%)
0.062
12 (30.0) 2 (11.1)
20 (50.0) 9 (50.0)
8 (20.0) 7 (38.9)
0.077
23 (57.5) 6 (33.3)
7 (17.5) 2 (11.1)
10 (25.0) 10 (55.6)
0.089
17 (42.5) 12 (66.7)
0.627
35 (87.5) 15 (83.3)
4 (10.0) 3 (16.7)
1 (2.5) 0 (0)
0.113
15 (37.5) 3 (16.7)
25 (62.5) 15 (83.3)
0.052
0 (0) 1 (6.7)
9 (24.3) 2 (13.3)
26 (70.3) 8 (53.3)
2 (5.4) 4 (26.7)
35 (94.6) 11 (73.3) 0.050
2 (5.4) 4 (26.7)
0.435
0 (0) 1 (5.6)
24 (60.0) 10 (55.6)
9 (22.5) 5 (27.8)
7 (17.5) 2 (11.1)
33 (82.5) 15 (88.2) 0.587
1.9 0.8 1.7 0.7 0.336
50.9 23.2 41.9 18.2 0.336
25 (62.5) 8 (44.4) 0.199
d as TO with a total occlusion duration longer than 3 months.
ptor blocker; CABG  coronary artery bypass graft; CAD  coronary
sion; DHP  dihydropyridine; ECG  electrocardiography; hsCRP 
 left ventricular ejection fraction; NA  not applicable; NT-proBNP 
ention; PESpaclitaxel-eluting stent(s); RWM regionalwallmotion;
d tomography; TO  total occlusion; VD  vessel disease; ZES Lu
define
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832status to determine the independent predictors of lumen
area increase. In the multivariate analysis, independent
predictors of lumen area increase were a poor collateral flow
(odds ratio [OR]: 14.8, 95% confidence interval [CI]: 1.28
to 172.8, p  0.032), a TO duration of longer than 3
months, that is, CTO (OR: 12.0, 95% CI: 1.92 to 74.2, p
0.008) at TO recanalization, and statin use (OR: 7.4, 95%
CI: 1.03 to 53.6, p  0.047) (Table 4).
Discussion
In this study, we found evidence of a flow-dependent
vascular remodeling process in human coronary arteries after
successful TO recanalization that was associated with in-
creases in lumen diameter, EEM diameter, lumen area,
EEM area, and LVEF. Overall, 69% of the patients with
successful TO recanalization showed lumen area increase
with a mean lumen diameter increase of 0.40  0.34 mm at
Table 2. Qualitative IVUS Analysis
Lumen Area
Increase
(n  40, 69%)
No Lumen Area
Increase
(n  18, 31%) p Value
Dissection
Baseline 1 (2.5) 1 (5.6) 0.528
Proximal edge/distal edge 1/0 0/1
6-month follow-up 1 (2.5) 0 (0) 0.999
Proximal edge/distal edge 1/0
Plaque prolapse
Baseline 7 (17.5) 4 (22.2) 0.724
6-month follow-up 1 (2.5) 1 (5.6) 0.528
Stent fracture
Baseline 0 0 NA
6-month follow-up 0 1 NA
Incomplete stent apposition
Baseline 8 (20.0) 4 (22.2) 0.999
Proximal edge/stent body/
distal edge
1/6/1 2/2/0
6-month follow-up 18 (45.0) 7 (38.9) 0.664
Proximal edge/stent body/
distal edge
0/15/3 1/6/0
Persistent 7 (17.5) 3 (16.7) 0.999
Proximal edge/stent body/
distal edge
1/5/1 1/2/0
Resolved 1 (2.5) 1 (5.6) 0.528
Proximal edge/stent body/
distal edge
1/0/0 0/1/0
Late-acquired 13 (32.5) 5 (27.8) 0.719
Proximal edge/stent body/
distal edge
0/10/3 0/4/1
Aneurysm
Baseline 1 (2.5) 0 (0) 0.999
6-month follow-up 1 (2.5) 0 (0) 0.999
Values are n (%) or n. The p values were determined by chi-square test.
IVUS intravascular ultrasound.the 6-month follow-up. In patients with lumen area in-crease, the frequency of ISA increased significantly during
the 6-month follow-up period, but not in those without
lumen area increase. Furthermore, we discovered that a poor
collateral flow to the distal reference segments, a TO
duration of longer than 3 months, and statin use were strong
independent predictors of lumen area increase. With the
help of IVUS, which permitted detailed, high-quality,
cross-sectional imaging of the coronary arteries in vivo, we
were able to precisely quantify vascular changes in reference
segments between the index PCI and the 6-month
follow-up after TO recanalization rather than relying on
quantitative coronary angiography—to the best of our
knowledge—for the first time.
Clinical implication of CTO recanalization. On the role of
TO recanalization, several retrospective analyses and
eta-analyses of CTO studies have shown mortality reduc-
ion in patients successfully treated with CTO recanaliza-
ion compared with those treated medically (8,13,14). A
ossible explanation for the clinical benefit of CTO recan-
lization includes an improvement in LV function, a de-
rease in the rate of ventricular remodeling, and a decrease
n electrical instability and its associated risk for fatal
rrhythmic events (6,15,16).
When recanalizing CTO segments, the distal reference
egments in coronary angiograms usually appear very thin,
nviting the question of whether flow restoration of these
iny vessels will lead to any substantial improvement in
ardiac function and justify the risk of this complex proce-
ure at all, because CTO recanalization is more frequently
ssociated with various complications during PCI (17). We
howed that more than two-thirds of the patients after TO
ecanalization showed lumen area increase in the distal
eference segments along with improved LVEF 6 months
fter PCI. This vascular remodeling process with better
oronary flow might contribute to improved myocardial
unction and clinical outcomes. This is consistent with the
nding that a significant improvement in LVEF was ob-
erved only in patients with positive vascular remodeling.
herefore, in selected patients with TO, the long-term
enefits of recanalization might outweigh the risk of the
rocedure-related complications.
Vascular remodeling and its clinical predictors. Hemody-
namic stimuli and intact endothelial function are 2 impor-
tant factors that influence vascular remodeling. Hemody-
namic stimuli, such as flow and circumferential stress,
induce arterial remodeling to achieve homeostasis of shear
stress and wall tension (1). In an animal experiment, a
reduction in blood flow caused a decrease in vessel diameter
(4), whereas elevated flow tended to increase it. In de novo
atherosclerosis, remodeling is a major determinant of lumi-
nal narrowing. As initial plaque growth narrowed the lumen
significantly, local shear stress increased (18). In a rabbit
model, the endothelium reacted to increasing flow with
nitric oxide production that led to chronic vasodilation (19).
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833But, whether this flow-dependent remodeling process also
takes place in human coronary arteries has not been an-
swered yet.
In our study, a TO duration of longer than 3 months, a
poor collateral flow, and statin use were independent pre-
dictors of lumen area increase after recanalization. The
degree of collateral flow might reflect the magnitude of
Figure 1. Parameters of Vascular Remodeling at Baseline and at 6-Month
There was a signiﬁcant increase in lumen diameter by 0.21 mm (2.24  0.48
EEM diameter by 0.13 mm (2.91  0.70 mm at baseline and 3.05  0.69 mm
mm2 at baseline and 4.87  2.38 mm2 at 6-month follow-up, p  0.001) (C),
mm2 at 6-month follow-up, p  0.001) (D). EEM  external elastic membrane
Figure 2. Change of Lumen Area Between Baseline and 6 Months
After TO Recanalization of the 58 Patients
The y axis shows the lumen area change for each patient. Sixty-nine per-
cent of patients showed lumen area increase, whereas 31% did not.hemodynamic stimuli deprivation, whereas the TO duration
correlates with the time in which vessels undergo a negative
remodeling process. Therefore, patients with long TO
durations and severely compromised collateral flow would
have already undergone more extensive negative remodeling
compared with those with short TO durations and good
collateral flow (20). By contrast, these patients would react
-Up
at baseline and 2.45  0.59 mm at 6-month follow-up, p  0.001) (A), in
month follow-up, p  0.010) (B), in lumen area by 0.87 mm2 (4.00  1.90
EEM area by 0.85 mm2 (6.80  3.21 mm2 at baseline and 7.65  3.41
Table 3. Frequency of Incomplete Stent Apposition
6-Month Follow-Up
p ValueISA () ISA ()
All patients
Baseline
ISA () 31 15 0.002
ISA () 2 10
Patients with lumen area increase
Baseline
ISA () 21 11 0.006
ISA () 1 7
Patients without lumen area increase
Baseline
ISA () 10 4 0.375
ISA () 1 3
The p values were determined by McNemar test.Follow
mm
at 6-
and inISA incomplete stent apposition.
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834more intensively to flow restoration with lumen area in-
crease, given that we showed a positive correlation between
the duration of TO and changes in lumen area. By contrast,
patients with good collateral flow would have preserved
their lumen size due to the maintenance of hemodynamic
stimuli. Those patients would not necessarily undergo
lumen area increase after recanalization. Furthermore, statin
use was also a strong independent predictor of lumen area
increase. This is consistent with previous reports: Treasure
et al. (21) showed that statins improved endothelium-
mediated responses in the coronary arteries of patients with
Table 4. Independent Predictors of Lumen Area Increase
95% CI
p Value Odds Ratio Lower Upper
Poor collateral ﬂow
(vs. normal ﬂow)
0.032 14.8 1.28 172.8
CTO 0.008 12.0 1.92 74.2
Statin use 0.047 7.4 1.03 53.6
CTO, collateral flow grade, CAD extent, TO location, statin use, age, sex, diabetes mellitus, hyper-
tension, and smoking status were entered intomultivariate analysis. CTOwas defined as TOwith
a total occlusion duration longer than 3 months.
CI confidence interval; other abbreviations as in Table 1.
Figure 3. Coronary Angiogram and IVUS of 1 Representative Patient
(A) The image shows the baseline coronary angiogram of a patient before PCI
TO and its IVUS result (B) and the same patient at 6-month follow-up (C). Note th
(arrowheads in A, B (1), and C (1) and IVUS at 6-month follow-up. IVUS  intravasculaatherosclerosis. Furthermore, statins have been associated
with reduced progression and even regression of coronary
atherosclerosis (22).
Choosing the optimal stent size. Another interesting clinical
erspective involves the question of whether these clinical
redictors can be used for selection of the optimal stent size
uring PCI for a TO. The distal reference vessels appear to
e very “thin” in coronary angiography after successful
iring and balloon dilation, so that many operators tend to
hoose stents with small diameters. As shown in our study,
ore than two-thirds of the patients showed lumen area
ncrease in the distal reference segments at the 6-month
ollow-up. We showed that the mean increase in the lumen
iameter was 0.21 mm in all patients, and among those with
umen area increase, this was an even higher 0.40 mm. It is
lso important to note that patients with lumen area
ncreases would be more likely to experience incomplete
tent apposition during the follow-up period. Therefore,
hoosing a stent size only according to the distal reference
essel seen on angiography during index PCI might lead to
hoosing a stent that is too small if the vascular remodeling
s not considered (Fig. 3). By contrast, if a stent that is too
arge is chosen in expectation of excessive vascular remod-
. The coronary angiogram of the patient immediately after successful PCI for
ase in lumen size of the distal reference in both coronary angiogramto TO
e increr ultrasound; PCI  percutaneous coronary intervention; TO  total occlusion.
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835eling, as some operators practice according to their intu-
ition, it might cause vessel injury. Therefore, clinical pre-
dictors of lumen area increase would guide the operators in
choosing the optimal stent size. As such, in patients with a
long TO duration and a poor collateral flow, a larger stent
size could be considered, whereas oversized stent implanta-
tion could be avoided in TO without those predictors.
Study limitations. First, although the data were collected
rospectively, the precise duration of the occlusion was not
ngiographically documented, which means that the dura-
ion had to be assumed based on the patients’ history and
oninvasive test results. We believe that this limitation is
pplicable to all observational studies with CTO. Second,
e did not evaluate the ischemia and viability in the area
ubject of recanalization in all patients before PCI. Vessels
upplying areas without viability may be less prone to show
umen area increase. However, 72% of the study patients
ad positive results in at least 1 of the functional tests,
ncluding electrocardiography, echocardiography, treadmill
est, and myocardial perfusion imaging (Table 1), and the
est of the study patients had typical symptoms of myocar-
ial ischemia. Third, vascular remodeling implies an actual
hange in the arterial structure at the cellular levels. Because
iopsy of the human coronary artery is impossible, our data
elied on “surrogate markers,” such as the lumen and EEM
rea change, derived from IVUS examination. Further
tudies with virtual histology might answer some part of this
uestion. Fourth, because we measured vascular change over
6-month period, it is unknown whether it is safe to
mplant an oversized stent during initial PCI based on the
xpectation that over the next 6 months, the vessel might
row into the appropriate size. The result of the current
tudy is hypothesis-generating rather than definitive.
herefore, further prospective trials addressing this question
hould follow. Fifth, the results of this study may be prone
o type II error due to small sample size. In patients with
umen area increase, the coronary artery disease extent
eemed to be smaller, the TO vessels were more likely
ocalized in left anterior descending artery, the proportion of
atients with diabetes mellitus was lower, and the distal
eference segment was more likely to be localized in the
id-vessels. Therefore, if more patients were enrolled, these
arameters might have been revealed as significant predic-
ors of vascular remodeling. Nonetheless, the occlusion
uration, a poor collateral flow, and statin use were strong
ndependent predictors of lumen area increase despite the
mall size, suggesting that these parameters might be
owerful predictors of vascular remodeling. Further studies
ith enough sample size are warranted.
onclusions
Our study is the first that prospectively quantified vascular
changes of distal reference segments after TO recanalizationwith IVUS. The distal reference vessels underwent lumen
area increase after successful TO recanalization in only
two-thirds of the cases, and the clinical predictors of lumen
area increase included a TO duration of longer than 3
months, a poor collateral flow, and statin use. These
predictors could be considered for the selection of the
optimal stent size during PCI to TO lesions and optimal
medical therapy during follow-up.
Reprint requests and correspondence: Dr. Young-Seok Cho,
Internal Medicine, Seoul National University Bundang Hospital,
166 Gumi-ro, Bundang, Seongnam 463-707, South Korea.
E-mail: flammeus1@gmail.com.
REFERENCES
1. Langille BL. Arterial remodeling: relation to hemodynamics. Can
J Physiol Pharmacol 1996;74:834–41.
2. Ward MR, Pasterkamp G, Yeung AC, Borst C. Arterial remodeling.
Mechanisms and clinical implications. Circulation 2000;102:1186–91.
3. Pasterkamp G, Wensing PJ, Post MJ, Hillen B, Mali WP, Borst C.
Paradoxical arterial wall shrinkage may contribute to luminal narrowing
of human atherosclerotic femoral arteries. Circulation 1995;91:1444–9.
4. Langille BL, O’Donnell F. Reductions in arterial diameter produced by
chronic decreases in blood flow are endothelium-dependent. Science
1986;231:405–7.
5. Kahn JK. Angiographic suitability for catheter revascularization of total
coronary occlusions in patients from a community hospital setting. Am
Heart J 1993;126:561–4.
6. Stone GW, Kandzari DE, Mehran R, et al. Percutaneous recanaliza-
tion of chronically occluded coronary arteries: a consensus document:
part I. Circulation 2005;112:2364–72.
7. Stone GW, Reifart NJ, Moussa I, et al. Percutaneous recanalization of
chronically occluded coronary arteries: a consensus document: part II.
Circulation 2005;112:2530–7.
8. Prasad A, Rihal CS, Lennon RJ, Wiste HJ, Singh M, Holmes DR Jr.
Trends in outcomes after percutaneous coronary intervention for
chronic total occlusions: a 25-year experience from the Mayo Clinic.
J Am Coll Cardiol 2007;49:1611–8.
9. Aziz S, Stables RH, Grayson AD, Perry RA, Ramsdale DR. Percuta-
neous coronary intervention for chronic total occlusions: improved
survival for patients with successful revascularization compared to a
failed procedure. Catheter Cardiovasc Interv 2007;70:15–20.
10. Hoye A, van Domburg RT, Sonnenschein K, Serruys PW. Percuta-
neous coronary intervention for chronic total occlusions: the Thorax-
center experience 1992–2002. Eur Heart J 2005;26:2630–6.
11. Mintz GS, Nissen SE, Anderson WD, et al. American College of
Cardiology clinical expert consensus document on standards for acqui-
sition, measurement and reporting of intravascular ultrasound studies
(IVUS): a report of the American College of Cardiology Task Force on
Clinical Expert Consensus Documents. J Am Coll Cardiol 2001;37:
1478–92.
12. Mintz GS, Popma JJ, Pichard AD, et al. Patterns of calcification in
coronary artery disease: a statistical analysis of intravascular ultrasound and
coronary angiography in 1155 lesions. Circulation 1995;91:1959–65.
13. Joyal D, Afilalo J, Rinfret S. Effectiveness of recanalization of chronic
total occlusions: a systematic review and meta-analysis. Am Heart J
2010;160:179–87.
14. Suero JA, Marso SP, Jones PG, et al. Procedural outcomes and
long-term survival among patients undergoing percutaneous coronary
intervention of a chronic total occlusion in native coronary arteries: a
20-year experience. J Am Coll Cardiol 2001;38:409–14.
15. Horie H, Takahashi M, Minai K, et al. Long-term beneficial effect of late
reperfusion for acute anterior myocardial infarction with percutaneous
transluminal coronary angioplasty. Circulation 1998;98:2377–82.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 5 , N O . 8 , 2 0 1 2
A U G U S T 2 0 1 2 : 8 2 7 – 3 6
Park et al.
Vascular Remodeling After CTO Recanalization
83616. Hochman JS, Choo H. Limitation of myocardial infarct expansion by
reperfusion independent of myocardial salvage. Circulation 1987;75:
299–306.
17. Shimony A, Zahger D, Van Straten M, et al. Incidence, risk factors,
management and outcomes of coronary artery perforation during
percutaneous coronary intervention. Am J Cardiol 2009;104:1674–7.
18. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ.
Compensatory enlargement of human atherosclerotic coronary arteries.
N Engl J Med 1987;316:1371–5.
19. Lamontagne D, Pohl U, Busse R. Mechanical deformation of vessel
wall and shear stress determine the basal release of endothelium-
derived relaxing factor in the intact rabbit coronary vascular bed. Circ
Res 1992;70:123–30.
20. Nishida T, Di Mario C, Briguori C, Albiero R, Colombo A. Charac-
terization of total occlusions with intracoronary ultrasound: the impor-
tance of the duration of occlusion. J Invasive Cardiol 2001;13:1–8.21. Treasure CB, Klein JL, Weintraub WS, et al. Beneficial effects of
cholesterol-lowering therapy on the coronary endothelium in patients
with coronary artery disease. N Engl J Med 1995;332:481–7.
22. Nissen SE, Tuzcu EM, Schoenhagen P, et al., for the REVERSAL
Investigators. Effect of intensive compared with moderate lipid-
lowering therapy on progression of coronary atherosclerosis: a random-
ized controlled trial. JAMA 2004;291:1071–80.
Key Words: collateral circulation  coronary occlusion 
coronary vessels  interventional ultrasonography  myocar-
dial revascularization.
APPENDIXFor supplemental figures, please see the online version of this article.
